BizToc

[ad_1]

This image provided by Eli Lilly shows the company's new Alzheimer’s drug Kisunla. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s.
AP/Eli Lilly and Company
toggle caption
AP/Eli Lilly and Company
WASHINGTON — U.S.…

[ad_2]